EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the PRMT5/Nur77 methylation axis enhances endometrial decidualization capacity and female fertility in preclinical models

Zhiwen Cao, Xinyu Cai, Jie Mei, Na Kong, Yang Liu, Xiaoyue Shen, Min Wu, Xin Zhen, Jianxin Sun, Rong Li, Ruiwei Jiang, Haixiang Sun und 1 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci178862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Zhiwen Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, State Key Laborat…. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Nuclear Receptor Subfamily 4, Group A, Member 1, Endometrium, Decidua. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Frontier Technologies R&D Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defective endometrial decidualization is one major cause of female infertility, yet the underlying mechanisms remain elusive. Here, we identified that protein arginine methyltransferase 5 (PRMT5), which was upregulated during decidualization and by progesterone stimulation, was markedly downregulated in the endometria of patients with recurrent implantation failure (RIF), along with a global reduction of symmetric dimethylarginine (SDMA). Uterine stroma-specific ablation of Prmt5 in mice severely impaired decidualization, leading to infertility. A multiomics analysis in human endometrial stromal cells (EnSCs) revealed that PRMT5 promoted decidualization primarily by catalyzing SDMA at arginine 346 (R346) of the orphan nuclear receptor Nur77, which directs its proper chromatin occupancy. Targeting the PRMT5/Nur77 methylation axis, we designed a peptide, Pep-Nur77 R346K , which rescued the decidualization of multiple preclinical models: PRMT5-deficient human EnSCs, both genetic knockout ( Prmt5 d/d ) and pharmacologically inhibited mouse models, and most importantly, primary RIF EnSCs. In a retrospective cohort of 114 participants, the correlated reductions of endometrial PRMT5/Nur77-R346me2s were confirmed, which demonstrated robust predictive value for pregnancy outcome. Our work establishes the PRMT5/Nur77 methylation axis as a key regulator of endometrial receptivity and highlights both a diagnostic biomarker and a peptide-based therapeutic potential for infertility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Arginine N-MethyltransferasesNuclear Receptor Subfamily 4, Group A, Member 1EndometriumDeciduaInfertility, FemaleFertilityFemaleAnimalsHumansMiceEmbryo ImplantationMice, KnockoutMethylation

Stichwörter der Autor:innen

FertilityGeneticsPeptidesReproductive biology

Substanzen

Protein-Arginine N-MethyltransferasesNuclear Receptor Subfamily 4, Group A, Member 1PRMT5 protein, humanPrmt5 protein, mouseNR4A1 protein, human

Autor:innen und Institutionen

  • Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, State Key Laboratory of Pharmaceutical Biotechnology, and.
  • Center for Molecular Reproductive Medicine, Nanjing University, Nanjing, Jiangsu, China.
  • State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Medicine, Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Jiangsu Human Reproductive Function Remodeling Engineering Research Center, Nanjing, Jiangsu, China.
  • Nanjing Clinical Medical Center for Reproductive Medicine, Nanjing, Jiangsu, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Frontier Technologies R&D Program of Jiangsu Province

Zitieren

APA

Cao, Z., Cai, X., Mei, J., Kong, N., Liu, Y., Shen, X., Wu, M., Zhen, X., Sun, J., Li, R., Jiang, R., Sun, H., & Yan, G. (2026). Targeting the PRMT5/Nur77 methylation axis enhances endometrial decidualization capacity and female fertility in preclinical models. Journal of Clinical Investigation. https://doi.org/10.1172/jci178862

Vancouver

Cao Z, Cai X, Mei J, Kong N, Liu Y, Shen X, et al. Targeting the PRMT5/Nur77 methylation axis enhances endometrial decidualization capacity and female fertility in preclinical models. Journal of Clinical Investigation. 2026. doi:10.1172/jci178862

BibTeX
@article{Cao2026,
  author = {Cao, Zhiwen and Cai, Xinyu and Mei, Jie and Kong, Na and Liu, Yang and Shen, Xiaoyue and Wu, Min and Zhen, Xin and Sun, Jianxin and Li, Rong and Jiang, Ruiwei and Sun, Haixiang and Yan, Guijun},
  title = {Targeting the PRMT5/Nur77 methylation axis enhances endometrial decidualization capacity and female fertility in preclinical models},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci178862}
}
Kostenlos starten →